MELIS, MIRIAM
 Distribuzione geografica
Continente #
EU - Europa 181.963
NA - Nord America 5.386
AS - Asia 844
SA - Sud America 36
OC - Oceania 26
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 188.274
Nazione #
IT - Italia 180.636
US - Stati Uniti d'America 5.349
CN - Cina 550
UA - Ucraina 442
SE - Svezia 345
GB - Regno Unito 157
DE - Germania 133
FI - Finlandia 124
SG - Singapore 124
FR - Francia 48
VN - Vietnam 36
CA - Canada 35
IN - India 26
KR - Corea 25
AU - Australia 24
BR - Brasile 19
BE - Belgio 16
PH - Filippine 16
NL - Olanda 13
HK - Hong Kong 12
IR - Iran 11
CZ - Repubblica Ceca 10
IL - Israele 10
MY - Malesia 9
AR - Argentina 8
EU - Europa 8
IE - Irlanda 7
PL - Polonia 7
EC - Ecuador 5
NG - Nigeria 4
PK - Pakistan 4
TH - Thailandia 4
TR - Turchia 4
AT - Austria 3
CL - Cile 3
ES - Italia 3
GR - Grecia 3
JP - Giappone 3
ZA - Sudafrica 3
BD - Bangladesh 2
CR - Costa Rica 2
DK - Danimarca 2
EG - Egitto 2
HU - Ungheria 2
KE - Kenya 2
LK - Sri Lanka 2
LT - Lituania 2
NZ - Nuova Zelanda 2
RS - Serbia 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CH - Svizzera 1
CO - Colombia 1
IQ - Iraq 1
IS - Islanda 1
MK - Macedonia 1
MT - Malta 1
PT - Portogallo 1
Totale 188.274
Città #
Cagliari 180.010
Fairfield 894
Woodbridge 628
Ashburn 365
Houston 355
Chandler 348
Seattle 332
Ann Arbor 320
Uta 318
Wilmington 300
Cambridge 283
Nyköping 281
Jacksonville 231
Dearborn 147
Beijing 88
Boardman 87
Nanjing 78
Shanghai 74
Boston 70
Singapore 59
Helsinki 57
New York 54
San Diego 50
Dong Ket 36
Nanchang 34
Guangzhou 32
Redwood City 32
Hebei 28
Los Angeles 26
Shenyang 25
Jiaxing 22
London 22
Milan 21
Seoul 21
Norwalk 20
Mountain View 19
Tianjin 18
Toronto 18
Changsha 15
Brussels 13
Falls Church 12
Jinan 11
Kunming 9
Melbourne 9
Zhengzhou 9
Atlanta 8
Augusta 8
Hefei 8
Leawood 8
Orange 8
Phoenix 8
San Mateo 8
Sassari 8
Verona 8
Auburn Hills 7
Bacolod City 7
Dublin 7
Ningbo 7
Pune 7
Haifa 6
Hong Kong 6
Kuching 6
Leicester 6
Sèlegas 6
Torino 6
Bloomington 5
Brno 5
Columbus 5
Hialeah 5
Rome 5
Taizhou 5
Washington 5
Ardabil 4
Berlin 4
Berwick 4
Borås 4
Brisbane 4
Buenos Aires 4
Buffalo 4
Central 4
Guayaquil 4
Maipú 4
Quartu Sant'elena 4
Southwark 4
Athens 3
Centro 3
Ceska 3
Chicago 3
Chiswick 3
Detroit 3
Edinburgh 3
Hastings 3
Heze 3
Johannesburg 3
Kilburn 3
Kocaeli 3
Kuala Lumpur 3
Las Vegas 3
Markham 3
Montague 3
Totale 186.155
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.503
Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area 5.143
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.378
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 3.925
Maternal immune activation disrupts dopamine system in the offspring 3.913
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.326
Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 3.311
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.162
Editorial: Exploring gender and sex differences in behavioral dyscontrol: From drug addiction to impulse control disorders 3.061
Sex differences in addictive disorders 2.969
null 2.940
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 2.892
Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation 2.820
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 2.802
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.552
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.464
New vistas on cannabis use disorder 2.438
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 2.417
null 2.394
NMDARs mediate the role of monoamine oxidase A in pathological aggression 2.380
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.366
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a G alpha(i/o) protein inhibitor 2.351
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.341
PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmission 2.260
Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system 2.245
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.236
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.187
Sex differences in impulsive and compulsive behaviors: a focus on drug addiction 2.181
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.152
Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction 2.147
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.054
Rehabilitating the addicted brain with transcranial magnetic stimulation 1.967
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 1.871
Altered chloride homeostasis decreases the action potential threshold and increase hyperexcitability in hippocampal neurons 1.846
null 1.722
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.687
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.625
Cannabinoid-dopamine interactions: Modulation of midbrain DA neurons by endocannabinoids 1.623
Optogenetic inhibition of chemically induced hypersynchronized bursting in mice 1.620
Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission 1.605
Endocannabinoids and lipid mediators in brain functions 1.583
Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone 1.511
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.506
Gender differences in the outcome of offspring prenatally exposed to drugs of abuse 1.441
Consequences of Perinatal Cannabis Exposure 1.429
Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects 1.363
The endocannabinoid system and nondrug rewarding behaviours 1.348
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.293
Exercise craving potentiates excitatory inputs to ventral tegmental area dopaminergic neurons 1.293
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.288
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.239
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.096
Role of 2-arachidonoylglycerol-mediated plasticity at inhibitory synapses onto midbrain dopamine neurons in increased consumption of and preference for ethanol in Sardinian alcohol-preferring rats 1.073
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.034
I CANNABINOIDI ATTIVANO I NEURONI DOPAMINERGICI DEL SISTEMA MESOLIMBICOCORTICALE 1.029
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 1.002
Mesolimbic dopamine dysregulation as a signature of information processing deficits imposed by prenatal THC exposure 983
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 980
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 974
Endocannabinoids and the processing of value-related signals 958
Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modulation of mesolimbic dopaminergic transmission 949
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 922
Fatty acid ethanolamides pinpoint nicotinic receptors and modulate neuronal excitability through nuclear receptor PPARα 921
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 916
A role for midbrain 2-arachidonoylglycerol signalling in increased consumption of and preference for ethanol in Sardinian alcohol-preferring rats 908
COR758, a negative allosteric modulator of GABAB receptors 896
null 850
null 841
Choosing the right drug: status and future of endocannabinoid research for the prevention of drug-seeking reinstatement 817
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 815
null 800
Chronic morphine and naltrexone fail to modify µ-opioid receptor mRNA levels in the rat brain 790
Endocannabinoids mediate pre-synaptic inhibition of glutamatergic transmission in rat VTA DA neurons through activation of CB1 receptors 748
null 747
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 722
The dopamine hypothesis of drug addiction: hypodopaminergic state 716
Strain specific synaptic modifications on ventral tegmental area dopamine neurons after ethanol exposure 680
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 675
From surface to nuclear receptors: the endocannabinoid family extends its assets 654
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 617
Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure 601
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 595
Use of marijuana: effect on brain health and cognitive impairment 584
Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system 551
Ethanol and acetaldehyde action on central dopamine systems: mechanisms,modulation and relation to stress 546
Different mechanism for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain 530
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 527
Crucial role of acetaldehyde in alcohol activation of the mesolimbic dopamine system 496
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. 480
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 471
Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids 463
Presynaptic nanoscale components of retrograde synaptic signaling 458
Clozapine potently stimulates mesocortical dopamine neurons 454
Electrophysiological effects of cannabinoids in the basal ganglia 450
COX- Inhibitors increase morphine effects on mesolimbic dopamine neurons 436
The cyclo-oxygenase inhibitor nimesulide induce conditioned place preference in rats 430
Cannabinoids activate mesolimbic dopamine neurons by an action on CB1 receptors 416
Mesolimbic dopaminergic decline after cannabinoid withdrawal 412
Clozapine does activate does activate nigrostriatal dopamine neurons in unanesthetized rats 411
Haloperidol does not produce dopamine cell depolarization-block in paralyzed,unanesthetized rats 390
Totale 186.984
Categoria #
all - tutte 217.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025.247 0 0 167 466 10.282 7.409 3.681 783 598 575 610 676
2020/202137.378 1.127 1.438 1.622 10.508 7.720 3.994 2.907 2.098 897 1.942 1.905 1.220
2021/202211.125 923 872 524 643 961 948 668 629 703 1.176 1.700 1.378
2022/202313.594 1.238 1.520 1.338 1.215 1.305 1.569 711 872 883 978 1.314 651
2023/202448.543 739 651 514 857 1.327 2.142 2.309 829 749 949 1.561 35.916
2024/202514.814 6.404 7.091 1.319 0 0 0 0 0 0 0 0 0
Totale 188.601